IMPORTANT INTERCEPT PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of inve

Oct 05, 2017 20:53 pm UTC| Business

NEW YORK, Oct. 05, 2017 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern District of New York...

Smithfield Foods’ Helping Hungry Homes® Works With Walmart to Donate More Than 37,000 Pounds of Protein to Northwest Arkansas Food Bank

Oct 05, 2017 20:40 pm UTC| Business

LOWELL, Ark., Oct. 05, 2017 -- Today, Smithfield Foods’ Helping Hungry Homes® initiative, a program focused on alleviating hunger and helping Americans become more food secure, joined forces with Walmart to donate more...

Zogenix Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Oct 05, 2017 20:35 pm UTC| Business

EMERYVILLE, Calif., Oct. 05, 2017 -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, announced today the closing of its...

IKONICS Enters Dye Sublimation Market

Oct 05, 2017 20:32 pm UTC| Business

DULUTH, Minn., Oct. 05, 2017 -- IKONICS Corporation (NASDAQ:IKNX), a Duluth-based imaging technology company, announced that it has received a $258,000 purchase order for SubTHAT!™, a new internally developed product...

Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin

Oct 05, 2017 20:30 pm UTC| Business

COLUMBIA, Md., Oct. 05, 2017 -- Osiris Therapeutics, Inc. (Pink Sheets:OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine,...

Retrophin Announces Presentation of New Data from Physician-Initiated Treatment with Fosmetpantotenate at the Child Neurology Society’s 26th Annual Meeting

Oct 05, 2017 20:30 pm UTC| Business

SAN DIEGO, Oct. 05, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced the presentation of new data from physician-initiated treatment with fosmetpantotenate (RE-024), the Company's novel, investigational replacement...

Franklin Resources, Inc. to Announce Fourth Quarter and Fiscal Year Results on October 26, 2017

Oct 05, 2017 20:30 pm UTC| Business

SAN MATEO, Calif., Oct. 05, 2017 -- On Thursday, October 26, 2017, Franklin Resources, Inc. (the “Company”) (NYSE:BEN) will release its fourth fiscal quarter and fiscal year 2017 operating results at approximately 8:30...